(Q80176025)
Statements
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients (English)
Edwin DeJesus
Daniel Berger
Martin Markowitz
Calvin Cohen
Trevor Hawkins
Peter Ruane
Richard Elion
Charles Farthing
Lijie Zhong
Andrew K Cheng
Damian McColl
Brian P Kearney
183-0101 Study Team
1 September 2006